![]() | Up a level |
Journal Article
Cuypers, L., Vrancken, B., Fabeni, L., Di Maio, V. C., Cento, V., Baele, G., Parczewski, M., Chulanov, V., Gomes, P., Beloukas, A., Geretti, A. M., Dietz, J., Sarrazin, C., Neary, M., Degascun, C., Sierra, S., Kaiser, R., Jimenez, A. B. P., Garcia, F. G., Zazzi, M., Vandamme, A. -M. and Silberstein, F. C. (2018). Inferring the migration routes of hepatitis C virus subtype 1a lineages identifies a need for pan-European prevention strategies. J. Hepatol., 68. S. S158 - 2. AMSTERDAM: ELSEVIER SCIENCE BV. ISSN 1600-0641
Rupp, D., Dietz, J., Sikorski, M. A., Sierra, S., Brown, R., Pietschmann, T., Kaiser, R., Sarrazin, C. and Bartenschlager, R. (2015). A phenotypic NS3-protease inhibitor resistance assay to characterize resistance-associated mutations in patients. J. Viral Hepatitis, 22. S. 93 - 94. HOBOKEN: WILEY-BLACKWELL. ISSN 1365-2893
Wiesmann, F., Naeth, G., Sarrazin, C., Berger, A., Kaiser, R., Ehret, R., Knechten, H. and Braun, P. (2015). Variation analysis of six HCV viral load assays using low viremic HCV samples in the range of the clinical decision points for HCV protease inhibitors. Med. Microbiol. Immunol., 204 (4). S. 515 - 526. NEW YORK: SPRINGER. ISSN 1432-1831